At a glance
ClinicalIndex Comparison RecordN/ACompleted· 83 enrolled
Drug / intervention
FreeStyle Libre Flash Glucose Monitoring Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Accuracy of the FreeStyle Libre Flash Glucose Monitoring System - Use in Pregnancy
In Brief
A clinical study evaluating FreeStyle Libre Flash Glucose Monitoring System for Diabetes Mellitus. Completed, enrolled 83 participants across 13 sites in 2 countries.
Detailed Summary
To evaluate the point accuracy of the FreeStyle Libre Flash Glucose Monitoring System when used at home by pregnant women with diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesAustria, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
First PostedJan 2016
Primary CompletionJun 2016
Study CompletionSep 2016
TodayJul 2026
First PostedJan 27, 2016
Enrollment StartJan 1, 2016
Primary CompletionJun 1, 2016
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 10.4 years ago
Interventions
FreeStyle Libre Flash Glucose Monitoring Systemdevice
Subjects will wear the FreeStyle Libre Flash Glucose Monitoring System masked for 14 days. During these 14 days subjects will be asked to perform 4 blood glucose tests (pre-meals and before bedtime) per day. At the same time as the blood glucose test a sensor scan is performed.